San Francisco Sentry Investment Group’s AstraZeneca AZN Stock Holding History

San Francisco Sentry Investment Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$4K	Hold	34	–	–	﹤0.01%	578
2021 Q1	$3K	Sell	34 -273	-89%	-$27.4K	﹤0.01%	628
2020 Q4	$30K	Sell	307 -150	-33%	-$15.9K	0.01%	415
2020 Q3	$50K	Sell	457 -12	-3%	-$1.33K	0.03%	332
2020 Q2	$50K	Sell	469 -2	-0.4%	-$207	0.03%	326
2020 Q1	$42K	Hold	471	–	–	0.03%	301
2019 Q4	$47K	Sell	471 -2	-0.4%	-$188	0.02%	376
2019 Q3	$42K	Sell	473 -11	-2%	-$954	0.02%	394
2019 Q2	$40K	Buy	484 +132	+38%	+$10.3K	0.02%	395
2019 Q1	$28K	Buy	+352	New	+$27.7K	0.01%	455

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

San Francisco Sentry Investment Group's AZN Position: Q2 2021 in Review

San Francisco Sentry Investment Group held its AstraZeneca (AZN) position steady in Q2 2021 at 34 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #578.

San Francisco Sentry Investment Group first reported a position in AZN in Q1 2019 and has held it in 10 quarters since. The position peaked at $50K in Q3 2020. 769 funds tracked by Wall St. Rank hold AZN as of Q2 2021.

San Francisco Sentry Investment Group held 34 shares of AstraZeneca worth $4K as of Q2 2021.
San Francisco Sentry Investment Group left its AstraZeneca share count unchanged in Q2 2021.
AstraZeneca made up ﹤0.01% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #578 holding.
San Francisco Sentry Investment Group first reported a position in AstraZeneca in Q1 2019 and has held it in 10 quarters since.
San Francisco Sentry Investment Group's AstraZeneca position peaked at $50K in Q3 2020.
769 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.